Clinical Trials Browser

Phase NA × Adenocarcinoma of Lung × tislelizumab × Clear all

NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Phase NA Recruiting

Adenocarcinoma of Lung

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

Phase NA Unknown

Adenocarcinoma of Lung